Saudi Arabia signs non-binding vaccine agreement with CureVac
Saudi Arabia’s Pharmaceutical Industries and Medical supplies Corporation (Spimaco) signed a non-binding agreement with CureVac. CureVac is a German pharmaceutical company. CureVac... Read More
Boehringer Ingelheim and CureVac announce collaboration to develop next generation lung cancer immunotherapy
Posted on25 Sep 2014
Comments0
Boehringer Ingelheim obtains exclusive global rights for development and commercialisation of CureVac’s investigational therapeutic cancer vaccine CV9202 CV9202 is based on CureVac’s... Read More